USD 3.05 MN
Sun Pharma to acquire 16.33 pc stake in Surgimatix for USD 3.05 mnSurgimatix is engaged in the business of developing a proprietary soft tissue fixation device for laparoscopic hernia repair and other mini...
Buy Dr. Reddy's Laboratories, target Rs 3,350: Edelweiss Financial ServicesBuy Dr. Reddy's Laboratories Ltd. at a price target of Rs 3350.0 .
Buy Vedanta, target Rs 425: Edelweiss Financial ServicesBuy Vedanta at a price target of Rs 425.
Sensex, Nifty rangebound; top 20 stock betsThe Nifty is trading in a narrow range, below its crucial psychological level of 7900, weighed down by losses in metal, IT and pharma.
Hot pick: What brokerage expect from Infosys Q3 resultsInfosys closed the year 2012 with a negative return of over 16 pc and was the worst performing stock among 30-stocks in the Sensex.
Load More